Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 9 years
- Director since
- 2023
9 years of board service in total across 3 boards, counting each seat separately. Longest: Enliven Therapeutics Inc., 3 years.
Enliven Therapeutics Inc.
Director
Skye Bioscience Inc.
Director
CAMP4 Therapeutics Corporation
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 23, 2026 | Skye Bioscience Inc. | Open-market sale | −114,851 | $1.61 | $184,910 |
| Sep 23, 2026 | Skye Bioscience Inc. | Open-market sale | −4,528 | $1.61 | $7,290 |
| Sep 22, 2026 | Skye Bioscience Inc. | Open-market sale | −27,612 | $1.65 | $45,560 |
| Sep 22, 2026 | Skye Bioscience Inc. | Open-market sale | −1,088 | $1.65 | $1,795 |
| Sep 16, 2026 | Skye Bioscience Inc. | Open-market sale | −32,607 | $1.91 | $62,279 |
| Sep 16, 2026 | Skye Bioscience Inc. | Open-market sale | −1,285 | $1.91 | $2,454 |
| Aug 27, 2026 | CAMP4 Therapeutics Corporation | Open-market sale | −400,000 | $4.04 | $1,616,000 |
| Aug 24, 2026 | CAMP4 Therapeutics Corporation | Open-market sale | −10 | $4.50 | $45 |
| Aug 21, 2026 | CAMP4 Therapeutics Corporation | Open-market sale | −32,018 | $4.50 | $144,081 |
| Aug 20, 2026 | CAMP4 Therapeutics Corporation | Open-market sale | −114,700 | $4.54 | $520,738 |
| Aug 20, 2026 | Skye Bioscience Inc. | Open-market sale | −1,159 | $0.32 | $371 |
| Aug 20, 2026 | Skye Bioscience Inc. | Open-market sale | −46 | $0.32 | $15 |
| Aug 20, 2026 | Skye Bioscience Inc. | Open-market sale | −6,495 | $0.32 | $2,078 |
| Aug 19, 2026 | CAMP4 Therapeutics Corporation | Open-market sale | −45,147 | $4.76 | $214,900 |
| Aug 19, 2026 | Skye Bioscience Inc. | Open-market sale | −10,255 | $0.35 | $3,589 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.